Buprenorphine and Naloxone Sublingual Films Added to Portfolio
Camber Pharmaceuticals has launched buprenorphine and naloxone sublingual films [BUE-pre-NOR-feen and nal-OX-one suhb-ling-gwl], generic for Suboxone®.
Camber’s buprenorphine and naloxone sublingual films are available in 30 pouches per package in the following strengths: 2 mg/0.5 mg, 4 mg/1 mg, 8 mg/2 mg, and 12 mg/3 mg.
Buprenorphine and naloxone sublingual films contain buprenorphine, a partial-opioid agonist, and naloxone, an opioid antagonist, and is indicated for treatment of opioid dependence. Buprenorphine and naloxone sublingual films should be used as part of a complete treatment plan that includes counseling and psychosocial support.
See full prescribing information for the safe use of buprenorphine and naloxone sublingual films here.
For more product information, click here.
Recent articles
- Now Available from Camber: Topiramate Extended-Release Capsules, USP
- New Product Launch: Clomiphene Citrate Tablets, USP
- Camber Launches Raltegravir Tablets 400 mg
- Specialty Generics: Where Access Meets Affordability
- Buprenorphine and Naloxone Sublingual Films Added to Portfolio
- Buprenorphine and Naloxone Sublingual Tablets Added to Portfolio





